Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash Flows From Operating Activities
Net loss	$ (7,679,717)	$ (3,499,236)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	416,014	19,839
Depreciation and amortization expense	79,206	80,200
Deferred rent	(1,807)	(1,035)
Gain on sale of securities	37,882
Warrants issued to distributor	257,022
Stock-based compensation	1,040,909	610,763
Amortization of deferred financing costs	223,160	317,313
Paid-in-kind interest		77,805
Changes in assets and liabilities:
Accounts receivable	(674,683)	(814,530)
Inventory	(976,462)	73,528
Restricted cash		127,580
Prepaid expenses and other current assets	(162,558)	(8,015)
Other assets	6,325	5,271
Accounts payable	1,825,135	1,019,821
Accrued expenses	770,068	475,289
Total adjustments	2,840,211	1,983,829
Net cash used in operating activities	(4,839,506)	(1,515,407)
Cash Flows From Investing Activities
Proceeds from held-to-maturity investments	2,408,632
Purchases of property and equipment	(39,419)	(12,251)
Release of restricted cash	103,603
Purchase of short term investments	(26,747)
Net cash provided by (used in) investing activities	2,446,069	(12,251)
Cash Flows From Financing Activities
Repayment of automobile loans	(7,214)	(9,445)
Repayment of equipment loans	(16,418)	(18,080)
Repayment of line of credit	(1,280,275)	500,000
Payments of deferred offering costs		(43,383)
Proceeds from the January public offering, net of costs	1,429,740
Proceeds from the June public offering, net of costs	1,259,415
Proceeds from disgorgement of short swing profit		56,250
Proceeds from the sale of common stock and warrants, net of costs		861,790
Net cash provided by financing activities	1,385,248	1,347,132
Net decrease in cash	(1,008,189)	(180,526)
Cash, beginning of period	1,249,550	207,192
Cash, end of period	241,361	26,666
Cash paid for interest	3,450	6,844
Non-cash investing and financing activities:
Issuance of common stock to consultants, vendors and customers	872,252	136,532
Accrued deferred offering costs		192,158
Issuance of insurance obligation in accrued expenses	$ 75,150